Literature DB >> 15981079

MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.

Paraskevi Kosta1, Maria I Argyropoulou, Sofia Markoula, Spyridon Konitsiotis.   

Abstract

OBJECTIVE: To evaluate by MRI the area size and the degree of iron accumulation in basal ganglia nuclei that are implicated in the pathogenesis of Parkinson's disease (PD).
METHODS: 40 patients with idiopathic PD and 40 controls were examined on a 1. 5 Tesla MR imager, using a multiecho SE sequence 2000/20, 40, 60, 80, 100, 120, 140, 160 (TR/TE). The T2 relaxation time (T2) and the area of substantia nigra zona compacta (SNc), substantia nigra zona reticulata (SNr), putamen (Pu), globus pallidus external (GPe), globus pallidus internal (GPi), caudate nucleus (CN), locus coeruleus (LC) and subthalamic nucleus (STN) were assessed.
RESULTS: The T2 of SNc (76. 8 +/- 6. 0) was lower and of Pu (79.5 +/- 6.0) and GPe (69.5 +/- 7.0) was higher in patients than in controls (78.6 +/- 3.8, 77.4 +/- 3.9 and 67.3 +/- 5.7, respectively), p < 0.05. The area of CN (125.9 +/- 20.2) and Pu (201.5 +/- 48.7) was higher in patients than in controls (110.7 +/- 21.5 and 180.1 +/- 41.1, respectively), p < 0.05. A more pronounced decrease in the T2 of SNc (73.6 +/- 8.9) was observed when the more affected side of patients was evaluated separately. In patients with disease duration > 5 years the T2 of STN (71.5 +/- 6.3) was lower and the area of Pu was higher (215.3 +/- 54.9) compared with those with disease duration < or = 5 years (75.8 +/- 10.9 and 190.9 +/- 41.0 respectively), p < 0.05.
CONCLUSIONS: These findings suggest that dysfunction of the basal ganglia circuitry in PD may affect iron content not only in SNc but in STN, Pu and GPe as well. Compensatory sprouting of the remaining dopaminergic fibers could account for the increased area of the CN and Pu.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981079     DOI: 10.1007/s00415-005-0914-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  41 in total

1.  T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

Authors:  J Vymazal; A Righini; R A Brooks; M Canesi; C Mariani; M Leonardi; G Pezzoli
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

2.  Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes.

Authors:  M B Stern; B H Braffman; B E Skolnick; H I Hurtig; R I Grossman
Journal:  Neurology       Date:  1989-11       Impact factor: 9.910

3.  Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths.

Authors:  A Bizzi; R A Brooks; A Brunetti; J M Hill; J R Alger; R S Miletich; T L Francavilla; G Di Chiro
Journal:  Radiology       Date:  1990-10       Impact factor: 11.105

4.  Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.

Authors:  J B Schulz; M Skalej; D Wedekind; A R Luft; M Abele; K Voigt; J Dichgans; T Klockgether
Journal:  Ann Neurol       Date:  1999-01       Impact factor: 10.422

5.  Systematic expression of immediate early genes and intensive astrocyte activation induced by intrastriatal ferrous iron injection.

Authors:  M Hironishi; E Ueyama; E Senba
Journal:  Brain Res       Date:  1999-05-15       Impact factor: 3.252

6.  Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA.

Authors:  J M Hill
Journal:  Brain Res       Date:  1985-09-02       Impact factor: 3.252

7.  The regional distribution and cellular localization of iron in the rat brain.

Authors:  J M Hill; R C Switzer
Journal:  Neuroscience       Date:  1984-03       Impact factor: 3.590

8.  MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.

Authors:  Osvaldo P Almeida; Emma J Burton; Ian McKeith; Anil Gholkar; David Burn; John T O'Brien
Journal:  Dement Geriatr Cogn Disord       Date:  2003       Impact factor: 2.959

Review 9.  Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.

Authors:  D T Dexter; P Jenner; A H Schapira; C D Marsden
Journal:  Ann Neurol       Date:  1992       Impact factor: 10.422

10.  Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease.

Authors:  J M Gorell; R J Ordidge; G G Brown; J C Deniau; N M Buderer; J A Helpern
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910

View more
  45 in total

1.  Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours.

Authors:  P N Margariti; L G Astrakas; S G Tsouli; G M Hadjigeorgiou; S Konitsiotis; M I Argyropoulou
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

2.  Basal ganglia MR relaxometry in obsessive-compulsive disorder: T2 depends upon age of symptom onset.

Authors:  Stephen Correia; Emily Hubbard; Jason Hassenstab; Agustin Yip; Josef Vymazal; Vit Herynek; Jay Giedd; Dennis L Murphy; Benjamin D Greenberg
Journal:  Brain Imaging Behav       Date:  2009-12-12       Impact factor: 3.978

3.  Oxidative stress and 17-alpha- and 17-beta-estradiol modulate neurofilaments differently.

Authors:  Keith Chiasson; Vicky Lahaie-Collins; Julie Bournival; Benoit Delapierre; Sylvie Gélinas; Maria-Grazia Martinoli
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Human subthalamic nucleus: evaluation with high-resolution MR imaging at 3.0 T.

Authors:  Mika Kitajima; Yukunori Korogi; Shingo Kakeda; Junji Moriya; Norihiro Ohnari; Toru Sato; Yoshiko Hayashida; Toshinori Hirai; Tomoko Okuda; Yasuyuki Yamashita
Journal:  Neuroradiology       Date:  2008-04-29       Impact factor: 2.804

5.  Eye of the Tiger Sign and Very Late Onset in Dentatorubral-Pallidoluysian Atrophy.

Authors:  Joana Morgado; Sofia Reimão; Miguel Coelho; Mário M Rosa; Joaquim J Ferreira; Leonor Correia Guedes
Journal:  Mov Disord Clin Pract       Date:  2015-05-22

Review 6.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Authors:  Adriane Gröger; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

Review 7.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.

Authors:  Xiaojun Guan; Xiaojun Xu; Minming Zhang
Journal:  Neurosci Bull       Date:  2017-05-17       Impact factor: 5.203

Review 8.  Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review.

Authors:  Sara Pietracupa; Antonio Martin-Bastida; Paola Piccini
Journal:  Neurol Sci       Date:  2017-09-02       Impact factor: 3.307

9.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013

10.  Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.

Authors:  Anthony C Vernon; Saga M Johansson; Michel M Modo
Journal:  BMC Neurosci       Date:  2010-01-05       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.